SPAC144.17c Antibody

What is SPAC144.17c and why is it important in S. pombe research?

SPAC144.17c is a gene in Schizosaccharomyces pombe (fission yeast) with the UniProt accession number Q9UTK9 . Antibodies against this protein are important tools for studying its localization, expression, and function in various cellular processes. S. pombe serves as a model organism for fundamental cellular mechanisms including cell cycle regulation, chromosome dynamics, and stress responses, making antibodies against its proteins crucial for advancing our understanding of these processes.

What are the typical applications for SPAC144.17c antibody in research?

SPAC144.17c antibodies are primarily used in:

• Western blotting for protein expression analysis

• ELISA for quantitative protein detection

• Immunocytochemistry for localization studies

• Immunoprecipitation for protein-protein interaction studies

• Chromatin immunoprecipitation (ChIP) if the protein has DNA-binding functions

Applications should be validated for each specific experiment as optimal dilutions vary by laboratory and application .

How are antibodies against yeast proteins like SPAC144.17c typically generated?

Antibodies against yeast proteins are typically generated through several methods:

• Recombinant protein expression: The SPAC144.17c gene is cloned and expressed in E. coli or other expression systems.

• Protein purification: The recombinant protein is purified using affinity chromatography.

• Immunization: Animals (typically mice or rabbits) are immunized with the purified protein.

• Antibody screening: Generated antibodies are tested for specificity and sensitivity.

For monoclonal antibodies, hybridoma technology is commonly employed, involving fusion of B cells from immunized animals with myeloma cells to create immortalized antibody-producing cell lines .

What factors should be considered when designing experiments with SPAC144.17c antibody?

When designing experiments with SPAC144.17c antibody, researchers should consider:

• Antibody validation: Confirm specificity using knockout/knockdown controls

• Experimental conditions optimization:

  • Buffer composition and pH

  • Incubation time and temperature

  • Blocking reagents to minimize non-specific binding

  • Dilution series to determine optimal antibody concentration

• Appropriate controls: Include positive and negative controls

• Cross-reactivity assessment: Test potential cross-reactivity with similar proteins

• Signal-to-noise ratio optimization: Balance between specific signal detection and background reduction

For Western blots, optimizing lysis conditions is essential as yeast cells have rigid cell walls requiring specialized extraction protocols .

How should sample preparation be optimized for detecting SPAC144.17c in S. pombe lysates?

Optimal sample preparation for S. pombe lysates includes:

• Cell wall disruption techniques:

  • Mechanical disruption (glass beads, sonication)

  • Enzymatic treatment (zymolyase, lysing enzymes)

• Lysis buffer composition:

  • Detergent selection (Triton X-100, NP-40, SDS)

  • Protease inhibitors (PMSF, protease inhibitor cocktail)

  • Phosphatase inhibitors (if phosphorylation status is important)

• Sample handling:

  • Maintain cold temperatures throughout processing

  • Process samples quickly to prevent degradation

  • Avoid repeated freeze-thaw cycles

• Protein quantification:

  • Standardize loading based on total protein content

  • Use housekeeping proteins as loading controls

The harsh conditions needed for yeast cell disruption must be balanced with preserving the native state of the target protein .

What are the recommended storage conditions for maintaining SPAC144.17c antibody activity?

For optimal preservation of antibody activity:

• Short-term storage (up to 1 month): 2-8°C under sterile conditions after reconstitution

• Long-term storage (up to 6-12 months): -20 to -70°C under sterile conditions

• Avoid repeated freeze-thaw cycles using a manual defrost freezer

• Aliquoting reconstituted antibody into single-use volumes

• Addition of stabilizers such as glycerol (typically at 50%) for freeze storage

• Protection from light for conjugated antibodies

Following these guidelines helps maintain antibody performance for up to 12 months from the date of receipt .

What are common issues encountered when using SPAC144.17c antibody in Western blotting and how can they be resolved?

Appropriate controls should be included to distinguish between methodological issues and biological phenomena .

How can researchers validate the specificity of SPAC144.17c antibody?

Thorough validation of antibody specificity involves:

• Genetic approaches:

  • Testing in knockout/knockdown strains

  • Using strains with tagged versions of the target protein

• Biochemical approaches:

  • Peptide competition assays

  • Pre-adsorption tests

  • Mass spectrometry identification of immunoprecipitated proteins

• Immunological approaches:

  • Testing multiple antibodies targeting different epitopes

  • Comparing monoclonal and polyclonal antibody results

  • Cross-validation with orthogonal methods (e.g., fluorescent protein tagging)

• Controls:

  • Include isotype control antibodies

  • Test in different yeast species to assess cross-reactivity

  • Include positive controls of known concentration

Validation should be documented and referenced in publications to ensure experimental reproducibility .

How should researchers address discrepancies between SPAC144.17c antibody results and other experimental data?

When faced with discrepancies:

• Methodological validation:

  • Verify antibody specificity using alternative techniques

  • Test multiple antibody lots or sources

  • Optimize experimental conditions systematically

• Biological considerations:

  • Investigate potential post-translational modifications

  • Consider protein interactions that might mask epitopes

  • Examine cell/growth stage-specific expression patterns

  • Evaluate subcellular localization effects on detection

• Data integration approaches:

  • Correlate antibody-based data with -omics data (transcriptomics, proteomics)

  • Use orthogonal techniques (e.g., mass spectrometry)

  • Implement computational modeling to reconcile conflicting data

• Critical analysis:

  • Formulate testable hypotheses to explain discrepancies

  • Design targeted experiments to address specific inconsistencies

  • Consider publishing contradictory results with appropriate controls

This systematic approach helps distinguish between technical artifacts and novel biological insights .

How can SPAC144.17c antibody be used in multiplexed immunoassays with other S. pombe proteins?

Multiplexed immunoassays with SPAC144.17c antibody can be implemented through:

• Multiplex fluorescence imaging:

  • Use antibodies with non-overlapping host species

  • Employ antibodies with distinct fluorophores

  • Implement sequential staining protocols with appropriate blocking

  • Use zenon labeling or direct conjugation techniques

• Multiplex protein detection platforms:

  • Microarray-based detection systems

  • Bead-based multiplexing platforms

  • Nanoparticle-conjugated antibody systems

  • Sequential multiplexed Western blotting

• Study design considerations:

  • Validate absence of cross-reactivity between antibodies

  • Optimize signal-to-noise ratio for each target

  • Establish appropriate normalization controls

  • Account for potential steric hindrances between antibodies

These approaches allow simultaneous analysis of multiple proteins in the same sample, providing insight into complex protein networks and interactions in S. pombe .

What are the considerations for using SPAC144.17c antibody in ChIP-seq experiments if the protein has DNA-binding functions?

For ChIP-seq applications with SPAC144.17c antibody:

• Pre-experimental validation:

  • Confirm antibody specificity in immunoprecipitation

  • Validate DNA-binding capability of SPAC144.17c protein

  • Optimize crosslinking conditions specific to yeast cells

• Technical considerations:

  • Use appropriate sonication parameters for S. pombe chromatin

  • Implement robust controls (input, IgG, positive control ChIP)

  • Optimize antibody concentration and incubation conditions

  • Employ spike-in normalization for quantitative analyses

• Bioinformatic analysis:

  • Use S. pombe-specific genome annotations

  • Apply appropriate peak-calling algorithms

  • Implement quality control metrics for ChIP-seq data

  • Correlate binding sites with transcriptional outcomes

• Functional validation:

  • Confirm binding sites with orthogonal methods (e.g., ChIP-qPCR)

  • Correlate with gene expression changes

  • Perform mutagenesis of binding sites to confirm functionality

These approaches help ensure reliable chromatin immunoprecipitation data when studying DNA-protein interactions in S. pombe .

What emerging technologies can enhance the utility of SPAC144.17c antibody in structural and functional studies?

Cutting-edge technologies enhancing antibody-based research include:

• Advanced imaging approaches:

  • Super-resolution microscopy for detailed localization

  • Live-cell imaging with nanobody derivatives

  • Correlative light and electron microscopy (CLEM)

  • Expansion microscopy for improved spatial resolution

• Proximity labeling techniques:

  • BioID or TurboID fusion proteins for proximal protein identification

  • APEX-based proximity labeling

  • Split-BioID for protein interaction dynamics

• Single-cell applications:

  • Mass cytometry (CyTOF) for multiplexed protein detection

  • Microfluidic platforms for single-cell protein analysis

  • Spatial transcriptomics combined with protein detection

• AI-assisted antibody development:

  • Computational epitope prediction and antibody design

  • Machine learning for optimization of antibody properties

  • Development of synthetic antibodies with enhanced specificity

These technologies provide unprecedented insights into protein function, localization, and interactions in S. pombe at molecular resolution .

How does antibody-based detection of SPAC144.17c compare with CRISPR-based tagging approaches?

Both approaches have complementary strengths and limitations, and combining them can provide comprehensive insights into protein biology in S. pombe .

What strategies can integrate SPAC144.17c antibody data with proteomic and transcriptomic datasets?

Integrative approaches include:

• Correlation analyses:

  • Compare protein levels detected by antibodies with mRNA expression data

  • Identify discordance that may indicate post-transcriptional regulation

  • Correlate with global proteomic datasets from mass spectrometry

• Network integration:

  • Map antibody-detected interactions onto protein-protein interaction networks

  • Integrate with genetic interaction data from S. pombe screens

  • Develop predictive models incorporating multiple data types

• Temporal and spatial integration:

  • Align antibody-based localization data with compartment-specific -omics data

  • Correlate temporal expression patterns across different experimental platforms

  • Create integrated maps of protein dynamics during cellular processes

• Functional validation pipelines:

  • Design targeted validation experiments based on integrated predictions

  • Use CRISPR-based functional genomics to validate hypotheses

  • Implement systematic perturbation studies guided by integrated data

These integrative approaches enhance the biological context and significance of antibody-derived data .

How might advances in AI-based antibody engineering improve SPAC144.17c antibody performance?

AI-based approaches are revolutionizing antibody design and optimization:

• Epitope prediction and optimization:

  • Computational identification of optimal epitopes for antibody generation

  • Structure-based epitope accessibility analysis

  • Prediction of cross-reactivity with related proteins

• Antibody structure optimization:

  • Computational modeling of antibody-antigen binding interfaces

  • Affinity maturation through in silico mutagenesis

  • Stability enhancement through structural predictions

• High-throughput screening augmentation:

  • AI-guided selection of candidate antibodies

  • Predictive modeling of antibody performance across applications

  • Digital twin development for antibody behavior prediction

• Application-specific optimization:

  • Custom antibody design for specific techniques (ChIP, IF, WB)

  • Optimization of physicochemical properties for specific buffers

  • Species cross-reactivity engineering for comparative studies

These AI-driven approaches, as exemplified by the VUMC antibody discovery project, may lead to next-generation antibodies with superior specificity and performance characteristics .

What new insights might SPAC144.17c antibody research provide about conserved cellular mechanisms?

Research using SPAC144.17c antibody may illuminate:

• Evolutionary conservation of cellular pathways:

  • Comparative studies between S. pombe and other model organisms

  • Identification of conserved protein interactions and functions

  • Understanding of fundamental eukaryotic cellular mechanisms

• Novel protein functions:

  • Discovery of previously uncharacterized roles of SPAC144.17c

  • Identification of context-dependent protein activities

  • Elucidation of condition-specific regulation mechanisms

• Disease-relevant insights:

  • Connections between yeast pathways and human disease mechanisms

  • Conservation of stress response pathways relevant to pathological conditions

  • Identification of potential therapeutic targets through comparative biology

• Technological advancements:

  • Development of new methodologies applicable across model systems

  • Creation of innovative tools for protein visualization and analysis

  • Establishment of research paradigms for challenging protein targets

This research contributes to the broader understanding of fundamental biological processes with potential translation to human health applications .

What are the recommended best practices for publishing research using SPAC144.17c antibody?

Adhering to these best practices ensures reproducibility and reliability:

• Comprehensive reporting:

  • Include complete antibody information (catalog number, lot, host, clone)

  • Specify exact experimental conditions (dilutions, incubation times, buffers)

  • Document all optimization steps and validation procedures

  • Provide images of complete blots/gels with molecular weight markers

• Validation documentation:

  • Include specificity controls (knockout/knockdown validation)

  • Show titration experiments determining optimal antibody concentration

  • Present lot-to-lot consistency data if multiple lots were used

  • Validate for each specific application used in the study

• Data transparency:

  • Deposit raw data in appropriate repositories

  • Provide detailed protocols as supplementary materials

  • Include negative results and experimental limitations

  • Specify quantification methods for image analysis

• Statistical rigor:

  • Report biological and technical replicates clearly

  • Apply appropriate statistical tests with justification

  • Avoid image manipulation that could alter interpretation

  • Include power calculations for sample size determination

Following these practices aligns with the growing emphasis on reproducibility in biological research .